Table 1.
Number of visual outliers in SUV- and Patlak-derived measured metabolic volumes for both cancer
| Delineation method | NSCLC | GI cancer | ||
|---|---|---|---|---|
| SUV image | Patlak image | SUV image | Patlak image | |
| VOI50 | 9 | - | 5 | 3 |
| VOI70 | - | - | - | - |
| VOIA41 | 4 | 1 | 5 | 3 |
| VOIA50 | - | - | - | 1 |
| VOIA70 | - | - | - | - |
| VOIRTL | - | 1 | 3 | - |
| VOISchaefer | 2 | 2 | 3 | 2 |
| GradWT1 | - | 3 | 13 | 15 |
| GradWT2 | 2 | 5 | 5 | 5 |
NSCLC, non-small cell lung cancer; GI, gatrointestinal; SUV, standardized uptake value; VOI, volumes of interest; GradWT1, gradient-based watershed first approach; GradWT2, gradient-based watershed second approach.